Abilify (Aripiprazole) might seem to be the last thing that could help someone with chronic fatigue syndrome (ME/CFS). Abilify is a second-generation antipsychotic that is FDA approved for schizophrenia but is used off-label for depression, Parkinson’s disease, autism and many other diseases. If ME/CFS has never been associated with psychosis, why … Continue reading Abilify Shows Promise in Retrospective Chronic Fatigue Syndrome (ME/CFS) Study